United States · FDA National Drug Code directory
IBSRELA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73154-050_f077d878-d495-417c-b464-3e7c0c831be7
- Product NDC
- 73154-050
- Form
- TABLET
- Composition / generic term
- tenapanor hydrochloride
- Labeler
- Ardelyx, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190912
- Source listing expiry
- 20261231
Source-listed ingredients
- TENAPANOR HYDROCHLORIDE — 53.2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE (73154-050-06) · 73154-050-06
- 60 TABLET in 1 BOTTLE (73154-050-60) · 73154-050-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →